The light emitted by portable electronic devices (PEDs), particularly when used at night, has drawn a great deal of interest among sleep researchers, health-care professionals, and the media. Research shows that exposure to light at night (LAN) may be associated with poor sleep and may lead to diminished alertness and performance throughout the day. Exposure to LAN can also acutely suppress melatonin, a hormone produced at night and in darkness, which tells the body it is nighttime. The short-wavelength “blue” light emitted by electronics can be especially disruptive to melatonin production, and the proximity to the eye when PEDs are in use only aggravates the threat to getting a good night’s sleep.
In an effort to address this problem, in 2016 Apple Inc. released the Night Shift application for its line of PEDs, notably including the iPad, which in the third quarter of 2017 was the world’s most popular computer tablet and accounted for 25 perent of the year’s global tablet sales. The Night Shift mode permits users to change the screen’s color to “more warm” (i.e., less blue light) or “less warm” (i.e., more blue light), without necessarily changing its brightness. A new study from the Lighting Research Center (LRC) at Rensselaer investigated the effectiveness of Night Shift for lessening the impacts of nighttime iPad use on melatonin suppression, a marker of the circadian system. The study, to be published in 2018 by the peer-reviewed journal Lighting Research & Technology, is currently in press and is now available to subscribers online.
In the study, LRC researchers Rohan Nagare, Barbara Plitnick, and Mariana G. Figueiro recruited 12 young adults to view iPads between 11 p.m. and 1 a.m. on four separate nights under different experimental conditions.
Results showed that all three lighting interventions significantly suppressed melatonin over the two hours of each study night. More importantly, there was no significant difference between the effectiveness of the two Night Shift settings.
The study’s main takeaway is that changing screen color alone is insufficient for limiting the impact of PEDs on melatonin levels in the evening, and that screen brightness should also be reduced.
Overall, the results of this LRC study may be useful for developers, manufacturers, and users of self-luminous electronic devices by emphasizing considerations other than light spectrum when designing and using display applications for health and well-being. In addition to spectral properties, LRC researchers recommend that users also consider lowering the amount of light emitted by PEDs by keeping light levels low, limiting the use of PEDs to one-hour sessions, and avoiding exposures starting at least two hours before bedtime. Better yet, LRC researchers recommend turning off PEDs at least two hours prior to desired bedtimes. Even if melatonin is not suppressed during this interval, these devices can be alerting to the brain and, as a result, can disrupt sleep.